1667OResults of the TAPPAS trial: An adaptive enrichment phase III trial of TRC105 and pazopanib (P) versus pazopanib alone in patients with advanced angiosarcoma (AS)
Jones, R L; Ravi, V; Brohl, A S; Chawla, S P; Ganjoo, K; Italiano, A; Attia, S; Burgess, M; Thornton, K; Cranmer, L; Liu, L; Theuer, C; Maki, R
- 期刊名称Annals of Oncology
- 作者Jones, R L; Ravi, V; Brohl, A S; Chawla, S P; Ganjoo, K; Italiano, A; Attia, S; Burgess, M; Thornton, K; Cranmer, L; Liu, L; Theuer, C; Maki, R
- 卷第30卷
- 印刷ISSN0923-7534
- 电子ISSN1569-8041
- 文件大小107.52KB
- 发表时间2019-10-01
- DOI10.1093/annonc/mdz283